Next generation
near-patient diagnostics
Sexually transmitted infection management
Next generation near-patient diagnostics
Sexually transmitted infection management
Next generation near-patient diagnostics
Sexually transmitted infection management
Over 1 million new cases of sexually transmitted infections diagnosed every day, with an estimated market size of over $30 billion.
Sources: WHO, 2019 and Fior Markets, 2019
Our innovative technology using EXPAR and Linear Dichroism provides the results in under 15 minutes
Our innovative technology using EXPAR and Linear Dichroism provides the results in under 15 minutes
Designed for rapid Point-of Care testing for sexually transmitted infections and other infectious diseases
Technology
Our patented linear dichroism technology has a number of distinct advantages in that, not only does it provide very accurate results, but can measure multiple targets simultaneously
Solutions
Initially focused on sexually transmitted infections the technology can be utilised in a wide range of diagnostic applications
Delivering rapid results at the STI clinic
- Immediate treatment of positive patients
- Decrease onward transmission
- Lower the risk of antibiotic resistance
- Reduce healthcare costs
- Improve the patient experience
